Product development

Development of medicines and placebo for clinical trials and for patients


Development of formulations


The development of a new product/formulation for clinical trial starts with a physical-chemical characterisation of API (active substances), such as by determining particle size and particle size distribution, solubility and compatibility studies, and density measurement. Based on the results of these studies, we produce one or several composition proposals for preliminary stability studies.

Formulation of medicines and medical devices

Proposed formulations and manufacturing processes for medicine preparations and medicine-promixate products are developed. The proposals are based on the result of the pre-formulation studies and the desired product

Preparation forms

The preparation forms we develop include:

  • Water solutions
  • Suspensions
  • Emulsions
  • Injection medicines
  • Topical gels
  • Creams
  • Capsule preparations

Development of analysis methods

Analysis methods

We develop and validate the physical-chemical and microbiological analysis methods used to characterise products and in stability studies. We base these on the
product’s characteristics and propose a suitable method before carrying out development and validation. All work is carried out according to the ICH guidelines.


We work using techniques such as UPLC, HPLC, GC-fid, GC-headspace, HPLC-MS, GC-MS, IR, UV/vis, DSC, TGA and release analyses. We also have very long experience of wet chemical analysis according to pharmacopeia.

Stability studies

Product durability

To enable us to state product durability periods, we carry out stability studies to see how well they do over time and under differing conditions. We set up stability studies in climate rooms according to the ICH guidelines.

The scope of the stability studies is determined on the basis of the product durability required.

Pre-formulations, products in clinical trials and commercial products can all be put through stability studies.


When the excipient and the active substance are of equal importance

Together with our customers, we develop and produce new medicines with particular product characteristics.


Extemporeläkemedel och lagerberedningar

Beställ online via EbEx


Telefon: 010-447 97 00


Ordinarie öppettider:
Helgfria vardagar 08:00-17:00.


Öppettider sommar:
Helgfria vardagar 08:00-16:00.

Gäller 24 juni-16 augusti 2024.



Reservrutinen används endast för akuta medicinskt viktiga beställningar av extemporeläkemedel under tiden EbEx ordersystem inte kan nås. För att kunna använda dig av rutinen så krävs det att du redan är befintlig kund hos APL och har ett kundnummer.

Beställningar görs på för ändamålet avsedd blankett och får inte innehålla några patientuppgifter.

Beställningen skickas via e-post till



Visiting adress:

Prismavägen 2, Kungens Kurva

+46 10 447 96 00

Other contact information

About APL

Apotek Produktion & Laboratorier (APL) is one of Europe’s leading companies manufacturing extemporaneous drugs and stock preparations. We have a public policy assignment from the Swedish government, but also work together with other pharmaceutical companies to create the greatest possible patient benefit. The assignment also comprises preparedness to maintain operations in times of crisis and ultimately war.

Our vision is that we will make a difference for patients with special needs. We are also an established contract manufacturer within Life Science in Scandinavia, where we deliver services within development and analysis. With more than 500 employees and five manufacturing units in Malmö, Gothenburg, Stockholm and Umeå, we develop drugs that improve and save lives.

Read more